đ Maplebear Upgraded, Citigroup Upgraded, Integer Initiated and moreâŠ
RJ Hamster
Ratings changes for TRACON Pharmaceuticals, Hello Group, Natera, Tempest Therapeutics, Adicet Bio, Maplebear, Ironwood Pharmaceuticals and moreâŠText âMarketBeatâ to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.Learn More.
The Strategic Gold Play You Havenât Heard About (ad)
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock â but with less risk exposure.
Unlock the Power of Tomorrow with the #1 Alternative Energy Stock! (ad)
Are you ready to invest in a brighter, greener future? Look no further â the #1 Alternative Energy Stock is here, leading the charge towards sustainable and profitable solutions! By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
CEO Mark Zuckerberg sold 77,412 shares of the firmâs stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $495.66, for a total value of $38,370,031.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
CEO Mark Zuckerberg sold 31,493 shares of Meta Platforms stock in a transaction on Monday, March 11th. The stock was sold at an average price of $485.10, for a total value of $15,277,254.30. The transaction was disclosed in a filing with the SEC, which is available at this link.
Microsoft Co. (NASDAQ:MSFT) declared a quarterly dividend on Tuesday, November 28th. Stockholders of record on Thursday, February 15th will be paid a dividend of 0.75 per share by the software giant on Thursday, March 14th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Wednesday, February 14th.
Ashland (NYSE:ASH) was upgraded by analysts at Jefferies Financial Group Inc. from a âholdâ rating to a âbuyâ rating. They now have a $126.00 price target on the stock, up previously from $100.00. This represents a 31.9% upside from the current price of $95.51.
Citigroup (NYSE:C) was upgraded by analysts at The Goldman Sachs Group, Inc. from a âneutralâ rating to a âbuyâ rating. They now have a $68.00 price target on the stock. This represents a 18.7% upside from the current price of $57.31.
Maplebear (NASDAQ:CART) was upgraded by analysts at Sanford C. Bernstein from a âmarket performâ rating to an âoutperformâ rating. They now have a $43.00 price target on the stock, up previously from $30.00. This represents a 21.1% upside from the current price of $35.51.
The Goldman Sachs Group (NYSE:GS) was upgraded by analysts at Daiwa Capital Markets from a âneutralâ rating to an âoutperformâ rating. They now have a $430.00 price target on the stock, up previously from $410.00. This represents a 10.2% upside from the current price of $390.07.
Jack in the Box (NASDAQ:JACK) was upgraded by analysts at Wedbush from a âneutralâ rating to an âoutperformâ rating. They now have a $88.00 price target on the stock, up previously from $79.00. This represents a 21.1% upside from the current price of $72.64.
Marathon Oil (NYSE:MRO) was upgraded by analysts at Argus from a âholdâ rating to a âbuyâ rating. They now have a $31.00 price target on the stock. This represents a 18.6% upside from the current price of $26.13.
NewLake Capital Partners (OTCMKTS:NLCP) was upgraded by analysts at Compass Point from a âneutralâ rating to a âbuyâ rating. They now have a $18.25 price target on the stock. This represents a 10.9% upside from the current price of $16.45.
NeuroPace (NASDAQ:NPCE) was upgraded by analysts at Wells Fargo & Company from an âequal weightâ rating to an âoverweightâ rating. They now have a $20.00 price target on the stock, up previously from $16.00. This represents a 43.6% upside from the current price of $13.93.
Oracle (NYSE:ORCL) was upgraded by analysts at Argus from a âholdâ rating to a âbuyâ rating.The current price is $126.36.
UiPath (NYSE:PATH) was upgraded by analysts at JPMorgan Chase & Co. from a âneutralâ rating to an âoverweightâ rating. They now have a $28.00 price target on the stock, up previously from $22.00. This represents a 23.1% upside from the current price of $22.75.
Palomar (NASDAQ:PLMR) was upgraded by analysts at Jefferies Financial Group Inc. from a âholdâ rating to a âbuyâ rating. They now have a $88.00 price target on the stock, up previously from $78.00. This represents a 6.1% upside from the current price of $82.95.
RTX (NYSE:RTX) was upgraded by analysts at Wells Fargo & Company from an âequal weightâ rating to an âoverweightâ rating. They now have a $120.00 price target on the stock, up previously from $100.00. This represents a 30.1% upside from the current price of $92.26.
Solid Biosciences (NASDAQ:SLDB) was upgraded by analysts at Piper Sandler from a âneutralâ rating to an âoverweightâ rating. They now have a $20.00 price target on the stock, up previously from $8.00. This represents a 58.7% upside from the current price of $12.60.
Thomson Reuters (NYSE:TRI) (TSE:TRI) was upgraded by analysts at Barclays PLC from an âequal weightâ rating to an âoverweightâ rating. They now have a $180.00 price target on the stock, up previously from $150.00. This represents a 15.3% upside from the current price of $156.09.
Utz Brands (NYSE:UTZ) was upgraded by analysts at Bank of America Co. from a âneutralâ rating to a âbuyâ rating. They now have a $22.00 price target on the stock, up previously from $19.00. This represents a 21.1% upside from the current price of $18.17.
Williams-Sonoma (NYSE:WSM) was upgraded by analysts at Morgan Stanley from an âunderweightâ rating to an âequal weightâ rating. They now have a $270.00 price target on the stock, up previously from $155.00. This represents a 4.0% downside from the current price of $281.38.
Williams-Sonoma (NYSE:WSM) was upgraded by analysts at The Goldman Sachs Group, Inc. from a âsellâ rating to a âneutralâ rating. They now have a $263.00 price target on the stock, up previously from $154.00. This represents a 6.5% downside from the current price of $281.38.
I love this overnight trade happening Thursday (ad)
I call these trades âlive lottosâ as theyâre options trades I open on Thursday that expire on Friday. Weâre not going nuts here. Weâre putting in as little as $50 and hope to hit 300%⊠even 1,000% wins in 1 day like Iâve done with Nvidia and Amazon. They donât win every time, but itâs fun when they hit. Discover how I find these trades in my new free presentation.
Haynes International (NASDAQ:HAYN) was downgraded by analysts at Northcoast Research from a âbuyâ rating to a âneutralâ rating.The current price is $59.42.
Oportun Financial (NASDAQ:OPRT) was downgraded by analysts at Jefferies Financial Group Inc. from a âbuyâ rating to a âholdâ rating. They now have a $3.50 price target on the stock, down previously from $9.00. This represents a 0.6% downside from the current price of $3.52.
Paymentus (NYSE:PAY) was downgraded by analysts at Raymond James from an âoutperformâ rating to a âmarket performâ rating.The current price is $23.26.
Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at LADENBURG THALM/SH SH from a âbuyâ rating to a âneutralâ rating.The current price is $1.10.
Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at Royal Bank of Canada from an âoutperformâ rating to a âsector performâ rating. They now have a $2.00 price target on the stock, down previously from $9.00. This represents a 81.8% upside from the current price of $1.10.
Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at SVB Leerink LLC from an âoutperformâ rating to a âmarket performâ rating. They now have a $2.00 price target on the stock, down previously from $9.00. This represents a 81.8% upside from the current price of $1.10.
Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at Guggenheim from a âbuyâ rating to a âneutralâ rating.The current price is $1.10.
Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at HC Wainwright from a âbuyâ rating to a âneutralâ rating.The current price is $1.10.
UGI (NYSE:UGI) was downgraded by analysts at Wells Fargo & Company from an âoverweightâ rating to an âequal weightâ rating. They now have a $28.00 price target on the stock, up previously from $27.00. This represents a 14.7% upside from the current price of $24.42.
Why rely on luck when you can rely on expertise? Discover Don Kaufmanâs Ultima Trades, the revolutionary strategy that puts consistency at the forefront. With over 20 years of trading experience distilled into one comprehensive approach, success is no longer a gamble.
Absci (NASDAQ:ABSI) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $13.00 price target on the stock. This represents a 172.0% upside from the current price of $4.78.
AECOM (NYSE:ACM) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $106.00 price target on the stock. This represents a 16.0% upside from the current price of $91.34.
Atlas Energy Solutions (NYSE:AESI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a âbuyâ rating and a $24.00 price target on the stock. This represents a 10.7% upside from the current price of $21.69.
AGCO (NYSE:AGCO) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $142.00 price target on the stock. This represents a 21.9% upside from the current price of $116.48.
American Healthcare REIT (NYSE:AHR) is now covered by analysts at Barclays PLC. They set an âoverweightâ rating and a $18.00 price target on the stock. This represents a 31.1% upside from the current price of $13.73.
Alcon (NYSE:ALC) is now covered by analysts at Royal Bank of Canada. They set a âsector performâ rating on the stock.The current price is $87.04.
AMETEK (NYSE:AME) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $210.00 price target on the stock. This represents a 15.9% upside from the current price of $181.21.
Amkor Technology (NASDAQ:AMKR) is now covered by analysts at Fox Advisors. They set an âequal weightâ rating on the stock.The current price is $31.85.
Bitdeer Technologies Group (NASDAQ:BTDR) is now covered by analysts at Benchmark Co.. They set a âbuyâ rating and a $13.00 price target on the stock. This represents a 107.7% upside from the current price of $6.26.
Caterpillar (NYSE:CAT) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $390.00 price target on the stock. This represents a 14.0% upside from the current price of $342.17.
Cognex (NASDAQ:CGNX) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $47.00 price target on the stock. This represents a 14.8% upside from the current price of $40.93.
Cummins (NYSE:CMI) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $303.00 price target on the stock. This represents a 14.0% upside from the current price of $265.76.
Conduent (NASDAQ:CNDT) is now covered by analysts at Noble Financial. They set an âoutperformâ rating and a $9.00 price target on the stock. This represents a 182.1% upside from the current price of $3.19.
CNH Industrial (NYSE:CNHI) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $18.00 price target on the stock. This represents a 45.0% upside from the current price of $12.41.
Catalyst Pharmaceuticals (NASDAQ:CPRX) is now covered by analysts at Citigroup Inc.. They set a âbuyâ rating and a $27.00 price target on the stock. This represents a 65.8% upside from the current price of $16.28.
Deere & Company (NYSE:DE) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $494.00 price target on the stock. This represents a 30.2% upside from the current price of $379.38.
Fluor (NYSE:FLR) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $46.00 price target on the stock. This represents a 18.4% upside from the current price of $38.85.
Fortive (NYSE:FTV) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $99.00 price target on the stock. This represents a 16.3% upside from the current price of $85.12.
Robinhood Markets (NASDAQ:HOOD) is now covered by analysts at Sanford C. Bernstein. They set an âoutperformâ rating and a $30.00 price target on the stock. This represents a 61.2% upside from the current price of $18.61.
Integer (NYSE:ITGR) is now covered by analysts at CL King. They set a âbuyâ rating and a $137.00 price target on the stock. This represents a 20.2% upside from the current price of $113.94.
Illinois Tool Works (NYSE:ITW) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $301.00 price target on the stock. This represents a 13.5% upside from the current price of $265.31.
Jacobs Solutions (NYSE:J) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $154.00 price target on the stock. This represents a 3.1% upside from the current price of $149.35.
MasTec (NYSE:MTZ) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $96.00 price target on the stock. This represents a 12.9% upside from the current price of $85.00.
NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $35.00 price target on the stock. This represents a 59.8% upside from the current price of $21.90.
Oshkosh (NYSE:OSK) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $121.00 price target on the stock. This represents a 6.0% upside from the current price of $114.19.
PACCAR (NASDAQ:PCAR) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $117.00 price target on the stock. This represents a 2.3% upside from the current price of $114.37.
Parker-Hannifin (NYSE:PH) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $602.00 price target on the stock. This represents a 12.0% upside from the current price of $537.44.
Quanta Services (NYSE:PWR) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $301.00 price target on the stock. This represents a 24.5% upside from the current price of $241.74.
Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Cantor Fitzgerald. They set an âoverweightâ rating and a $60.00 price target on the stock. This represents a 138.1% upside from the current price of $25.20.
Sirius XM (NASDAQ:SIRI) is now covered by analysts at Guggenheim. They set a âneutralâ rating and a $4.00 price target on the stock. This represents a 1.7% downside from the current price of $4.07.
Terex (NYSE:TEX) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $73.00 price target on the stock. This represents a 26.4% upside from the current price of $57.75.
Tempest Therapeutics (NASDAQ:TPST) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $13.00 price target on the stock. This represents a 263.1% upside from the current price of $3.58.
United Rentals (NYSE:URI) is now covered by analysts at Truist Financial Co.. They set a âbuyâ rating and a $793.00 price target on the stock. This represents a 17.9% upside from the current price of $672.70.
Zebra Technologies (NASDAQ:ZBRA) is now covered by analysts at Truist Financial Co.. They set a âholdâ rating and a $300.00 price target on the stock. This represents a 6.5% upside from the current price of $281.66.
Sign up for MarketBeat All Access to gain access to MarketBeatâs full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatâs trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatâs happening in the market right now with MarketBeatâs real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeatâs free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (thatâs you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
